Posts by John

China is tightening its clinical trial oversight. Explore how this shift affects global drug development and the U.S. quest for improved research speed.

ICON and Anthropic are partnering to integrate generative AI into clinical trials. Discover how this shift will impact drug development and site operations.

A new AI audit framework fills the FDA's regulatory gap for mental health tools, focusing on clinical safety, diagnostic accuracy, and algorithmic fairness.

Akeso has dosed the first patient in a Phase II trial testing the combination of AK146D1 and ivonescimab to treat advanced breast cancer. Learn more.

A Mangaluru police official faces criminal charges for medical reimbursement fraud. Discover the impact on healthcare oversight and financial integrity.

Psychedelic therapy is nearing a clinical breakthrough. Explore the latest on MDMA and psilocybin research, regulatory shifts, and the future of psychiatry.

New research uncovers systemic barriers to pediatric cancer trial participation, urging for more equitable, inclusive, and accessible research strategies.

Are pharmaceutical giants suppressing peptide data? Discover the truth behind clinical research, patent limitations, and the risks of unregulated supplements.

The WHO advocates for new Ervebo vaccine clinical trials in DR Congo to strengthen Ebola defense, improve immunization strategies, and enhance public health.

The recent IND clearance for circular RNA CAR-T therapy is disrupting cell therapy trial standards. Discover how this innovation is reshaping oncology.